Rate of progression disease progression. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Cells, Cultured Tumor Cells, Cultured CD4-Positive T-Lymphocytes Cell Line Brain Kidney T-Lymphocytes CD8-Positive T-Lymphocytes Epithelial Cells Macrophages Fibroblasts Cell Nucleus Prostate Neoplastic Stem Cells

Organisms10

HIV-1 Mice, Transgenic Mice, Inbred C57BL Mice, Knockout Mice, Nude Simian immunodeficiency virus Mice, Inbred BALB C Macaca mulatta Mice, SCID HIV

Diseases60

Disease Progression Disease Models, Animal HIV Infections Prostatic Neoplasms Neoplasm Metastasis Breast Neoplasms Neoplasm Invasiveness Acquired Immunodeficiency Syndrome Cell Transformation, Neoplastic Neoplasms Adenocarcinoma Lung Neoplasms Melanoma Amyotrophic Lateral Sclerosis Skin Neoplasms Precancerous Conditions Neovascularization, Pathologic Neoplasm Recurrence, Local Liver Neoplasms Colorectal Neoplasms Alzheimer Disease Brain Neoplasms Simian Acquired Immunodeficiency Syndrome Carcinoma Inflammation Proteinuria Recurrence Kidney Diseases Liver Cirrhosis Urinary Bladder Neoplasms Multiple Myeloma Carcinoma, Squamous Cell Chronic Disease Kidney Neoplasms HIV Seropositivity Bone Neoplasms Ovarian Neoplasms Pancreatic Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Huntington Disease Atherosclerosis Genetic Predisposition to Disease Carcinoma, Renal Cell Carcinoma, Hepatocellular Kidney Failure, Chronic Fibrosis Atrophy Parkinson Disease Carcinoma, Non-Small-Cell Lung Arthritis, Rheumatoid Osteoarthritis, Knee Multiple Sclerosis Diabetic Nephropathies Glioblastoma Neoplasms, Hormone-Dependent Stomach Neoplasms Lymphatic Metastasis Neoplasms, Glandular and Epithelial Glioma Chromosome Aberrations

Chemicals and Drugs59

Biological Markers Tumor Markers, Biological Antineoplastic Agents RNA, Messenger Cell Cycle Proteins Neoplasm Proteins Antibodies, Monoclonal RNA, Small Interfering Antibodies, Monoclonal, Humanized Protein-Serine-Threonine Kinases Tumor Suppressor Protein p53 Transcription Factors Receptors, CCR5 Nuclear Proteins Deoxycytidine Cytokines Tumor Suppressor Proteins DNA-Binding Proteins Proto-Oncogene Proteins Cyclin-Dependent Kinases DNA Primers Cyclins Cyclin D1 Prostate-Specific Antigen Protein Kinase Inhibitors Fluorouracil Cyclin-Dependent Kinase Inhibitor p27 MicroRNAs Vascular Endothelial Growth Factor A Retinoblastoma Protein DNA, Neoplasm Paclitaxel RNA, Viral Pyrimidines Cisplatin Anti-HIV Agents Transforming Growth Factor beta Taxoids Androgens Receptors, Androgen Receptors, CXCR4 Carrier Proteins Quinazolines Enzyme Inhibitors Receptor, Epidermal Growth Factor Cadherins Angiogenesis Inhibitors Recombinant Proteins Antigens, CD Benzamides Doxorubicin Antineoplastic Agents, Phytogenic Membrane Proteins Piperazines Receptor, erbB-2 RNA, Neoplasm Cyclin-Dependent Kinase 2 Thalidomide Matrix Metalloproteinase 9

Analytical, Diagnostic and Therapeutic Techniques and Equipment61

Treatment Outcome Prognosis Disease Models, Animal Follow-Up Studies Immunohistochemistry CD4 Lymphocyte Count Survival Analysis Viral Load Disease-Free Survival Cohort Studies Antineoplastic Combined Chemotherapy Protocols Prospective Studies Neoplasm Staging Kaplan-Meier Estimate Retrospective Studies Survival Rate Reverse Transcriptase Polymerase Chain Reaction Risk Factors Gene Expression Profiling Severity of Illness Index Longitudinal Studies Drug Administration Schedule Predictive Value of Tests Blotting, Western Models, Biological Flow Cytometry Proportional Hazards Models Case-Control Studies Magnetic Resonance Imaging Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis Multivariate Analysis Neoplasm Transplantation Combined Modality Therapy Biopsy Transfection Reproducibility of Results Enzyme-Linked Immunosorbent Assay Sensitivity and Specificity Clinical Trials as Topic Antiretroviral Therapy, Highly Active Immunoenzyme Techniques Arthrography Transplantation, Heterologous Gene Knockdown Techniques Double-Blind Method Tumor Burden Infusions, Intravenous Real-Time Polymerase Chain Reaction Salvage Therapy Risk Assessment Treatment Failure Molecular Targeted Therapy Administration, Oral Drug Therapy, Combination Tissue Array Analysis Analysis of Variance Tomography, X-Ray Computed Orchiectomy Glomerular Filtration Rate Statistics, Nonparametric

Psychiatry and Psychology2

Alzheimer Disease Huntington Disease

Phenomena and Processes50

Cell Cycle Time Factors Gene Expression Regulation, Neoplastic CD4 Lymphocyte Count Cell Proliferation Viral Load Signal Transduction Mutation Apoptosis Phenotype Cell Division S Phase G1 Phase Up-Regulation Genotype Down-Regulation Cell Movement Mitosis Gene Expression Phosphorylation Base Sequence Drug Resistance, Neoplasm Gene Expression Regulation Alleles Dose-Response Relationship, Drug Amino Acid Sequence Transfection Cell Differentiation Cell Survival Tumor Microenvironment Sensitivity and Specificity Promoter Regions, Genetic Genetic Predisposition to Disease RNA Interference G2 Phase Transcription, Genetic Polymorphism, Genetic Gene Silencing Oxidative Stress DNA Methylation Gene Deletion Epithelial-Mesenchymal Transition Protein Binding Polymorphism, Single Nucleotide Genes, Tumor Suppressor Enzyme Activation Chromosome Aberrations Loss of Heterozygosity Glomerular Filtration Rate Virus Replication

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Survival Rate Molecular Sequence Data Base Sequence Amino Acid Sequence

Named Groups1

HIV Long-Term Survivors

Health Care26

Treatment Outcome Follow-Up Studies Survival Analysis Disease-Free Survival Cohort Studies Prospective Studies Kaplan-Meier Estimate Retrospective Studies Survival Rate Risk Factors Severity of Illness Index Longitudinal Studies Predictive Value of Tests Proportional Hazards Models Case-Control Studies Multivariate Analysis Reproducibility of Results Sensitivity and Specificity Clinical Trials as Topic Double-Blind Method Age Factors Risk Assessment Treatment Failure Analysis of Variance Age of Onset Statistics, Nonparametric

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care

Disease Progression Cell Cycle Treatment Outcome Prognosis Disease Models, Animal HIV Infections Time Factors Cell Line, Tumor HIV-1 Prostatic Neoplasms Neoplasm Metastasis Follow-Up Studies Gene Expression Regulation, Neoplastic Immunohistochemistry CD4 Lymphocyte Count Survival Analysis Cell Proliferation Viral Load Biological Markers Signal Transduction Tumor Markers, Biological Antineoplastic Agents Mutation Mice, Transgenic Disease-Free Survival Cohort Studies Breast Neoplasms Neoplasm Invasiveness Acquired Immunodeficiency Syndrome Antineoplastic Combined Chemotherapy Protocols Prospective Studies RNA, Messenger Neoplasm Staging Mice, Inbred C57BL Kaplan-Meier Estimate Cell Transformation, Neoplastic Retrospective Studies Survival Rate Reverse Transcriptase Polymerase Chain Reaction Apoptosis Risk Factors Neoplasms Adenocarcinoma Gene Expression Profiling Severity of Illness Index Cell Cycle Proteins Lung Neoplasms Phenotype Cell Division Longitudinal Studies Molecular Sequence Data Drug Administration Schedule Predictive Value of Tests Melanoma S Phase Cells, Cultured Blotting, Western Amyotrophic Lateral Sclerosis G1 Phase Models, Biological Flow Cytometry Tumor Cells, Cultured Up-Regulation Mice, Knockout Genotype CD4-Positive T-Lymphocytes Skin Neoplasms Down-Regulation Cell Movement Mitosis Neoplasm Proteins Mice, Nude Precancerous Conditions Neovascularization, Pathologic Neoplasm Recurrence, Local Cell Line Gene Expression Liver Neoplasms Proportional Hazards Models Colorectal Neoplasms Case-Control Studies Phosphorylation Base Sequence Magnetic Resonance Imaging Drug Resistance, Neoplasm Alzheimer Disease Antibodies, Monoclonal Brain Neoplasms Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis RNA, Small Interfering Simian Acquired Immunodeficiency Syndrome Gene Expression Regulation Carcinoma Antibodies, Monoclonal, Humanized Protein-Serine-Threonine Kinases Inflammation Proteinuria Tumor Suppressor Protein p53 Recurrence

No FAQ available that match "rate of progression disease progression"